Mechanisms of Disease: neuropathic pain - a clinical perspective

被引:548
作者
Baron, R
机构
[1] Univ Kiel, Dept Neurol Pain Res & Therapy, D-24105 Kiel, Germany
[2] Univ Kiel, Dept Neurol, D-24105 Kiel, Germany
来源
NATURE CLINICAL PRACTICE NEUROLOGY | 2006年 / 2卷 / 02期
关键词
mechanism-based and symptom-based assessment; neuropathic pain; neuroplastic changes; pathophysiological mechanisms; rational pharmacological treatment;
D O I
10.1038/ncpneuro0113
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropathic pain syndromes - pain after a lesion or disease of the peripheral or central nervous system - are clinically characterized by spontaneous and evoked types of pain, which are underpinned by various distinct pathophysiological mechanisms in the peripheral and central nervous systems. In some patients, the nerve lesion triggers molecular changes in nociceptive neurons, which become abnormally sensitive and develop pathological spontaneous activity. Inflammatory reactions of the damaged nerve trunk can induce ectopic nociceptor activity, causing spontaneous pain. The hyperactivity in nociceptors induces secondary changes in processing neurons in the spinal cord and brain, so that input from mechanoreceptive A-fibers is perceived as pain. Neuroplastic changes in the central pain modulatory systems can lead to further hyperexcitability. The treatment of neuropathic pain is still unsatisfactory, and a new hypothetical concept has been proposed, in which pain is analyzed on the basis of underlying mechanisms. The increased knowledge of pain-generating mechanisms and their translation into symptoms and signs might eventually allow a dissection of the mechanisms that operate in each patient. If a precise clinical phenotypic characterization of the neuropathic pain is combined with a selection of drugs that act on those mechanisms, it should ultimately be possible to design optimal treatments for individuals. This review discusses the conceptual framework of the novel mechanism-based classification, encouraging the reader to see neuropathic pain as a clinical entity rather than a compilation of single disease states.
引用
收藏
页码:95 / 106
页数:12
相关论文
共 70 条
[1]   Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat [J].
Alessandri-Haber, N ;
Dina, OA ;
Yeh, JJ ;
Parada, CA ;
Reichling, DB ;
Levine, JD .
JOURNAL OF NEUROSCIENCE, 2004, 24 (18) :4444-4452
[2]   Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain [J].
Ali, Z ;
Raja, SN ;
Wesselmann, U ;
Fuchs, PN ;
Meyer, RA ;
Campbell, JN .
PAIN, 2000, 88 (02) :161-168
[3]   Oscillatory mechanism in primary sensory neurones [J].
Amir, R ;
Liu, CN ;
Kocsis, JD ;
Devor, M .
BRAIN, 2002, 125 :421-435
[4]   The direct kinematics of parallel manipulators under joint-sensor redundancy [J].
Baron, L ;
Angeles, J .
IEEE TRANSACTIONS ON ROBOTICS AND AUTOMATION, 2000, 16 (01) :12-19
[5]   Activation of the somatosensory cortex during Aβ-fiber mediated hyperalgesia -: a MSI study [J].
Baron, R ;
Baron, Y ;
Disbrow, E ;
Roberts, TPL .
BRAIN RESEARCH, 2000, 871 (01) :75-82
[6]   Brain processing of capsaicin-induced secondary hyperalgesia - A functional MRI study [J].
Baron, R ;
Baron, Y ;
Disbrow, E ;
Roberts, TPL .
NEUROLOGY, 1999, 53 (03) :548-557
[7]   Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study [J].
Baron, R ;
Schattschneider, J ;
Binder, A ;
Siebrecht, D ;
Wasner, G .
LANCET, 2002, 359 (9318) :1655-1660
[8]  
Baron R, 1999, MUSCLE NERVE, V22, P678, DOI 10.1002/(SICI)1097-4598(199906)22:6<678::AID-MUS4>3.0.CO
[9]  
2-P
[10]   Histamine-induced itch converts into pain in neuropathic hyperalgesia [J].
Baron, R ;
Schwarz, K ;
Kleinert, A ;
Schattschneider, J ;
Wasner, G .
NEUROREPORT, 2001, 12 (16) :3475-3478